Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06)

The combination of avelumab and gemcitabine demonstrated promising efficacy and manageable safety in patients with advanced LMS who progressed on first-line therapy. Tumor-infiltrating lymphocyte density may be an important factor in predicting the response to combining immunotherapy with chemotherapy.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2024-10-18
DOI
https://doi.org/10.1002/cncr.35609
Citations
4
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06)

Taebum Lee, Wonyoung Choi, Jung Yong Hong, Koung Jin Suh et al.
4 citations
Cancer
Sarcoma Diagnosis and Treatment
1.68
article

Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06)

Taebum Lee, Wonyoung Choi, Jung Yong Hong, Koung Jin Suh, Yoon Ji Choi, Gyeong‐Won Lee, Mi Sun Ahn, Young Saing Kim, Yu Jung Kim, Chiyoon Oum, Se Hyun Kim, Sung Yong Oh, Jeongkyu Kim, Jeong Eun Kim, Su Jin Lee, Jin‐Hee Ahn, Jeeyun Lee, Jung Hoon Kim, Miso Kim, Juhyeon Jeong
article en
4 citations

Abstract

The combination of avelumab and gemcitabine demonstrated promising efficacy and manageable safety in patients with advanced LMS who progressed on first-line therapy. Tumor-infiltrating lymphocyte density may be an important factor in predicting the response to combining immunotherapy with chemotherapy.

CancerVol. 131(1)
Ulsan College (KR), Gachon University (KR), Ewha Womans University (KR), Korea University Medical Center (KR), Dong-A University Hospital (KR), Asan Medical Center (KR), Samsung Medical Center (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), University of Ulsan (KR), Gachon University Gil Medical Center (KR), Gyeongsang National University Hospital (KR), National Institute of Fisheries Science (KR), National Cancer Center (KR), Pusan National University Yangsan Hospital (KR), Ajou University (KR), Sungkyunkwan University (KR)
Merck KGaA
Good health and well-being
Openalex Percentile: Top 15%
Sarcoma Diagnosis and Treatment
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.